NCT02626507 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02626507
Title	Phase I Study of Combination of Gedatolisib With Palbociclib and Faslodex in Patients With ER+/HER2- Breast Cancer
Recruitment	Unknown status
Gender	female
Phase	Phase I
Variant Requirements	No
Sponsors	Eastchester Center for Cancer Care
Indications	Her2-receptor negative breast cancer
Therapies	Palbociclib Gedatolisib Goserelin Fulvestrant
Age Groups:	adult
Covered Countries	USA

Facility	Status	City	State	Zip	Country	Details
California Research Institute		Los Angeles	California	90027	United States	Details
Hoffman Oncology		The Bronx	New York	10469	United States	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT02626507Clinical Trial Detail